A single dose of pegfilgrastim compared with daily filgrastim for supporting neutrophil recovery in patients treated for low-tointermediate risk acute myeloid leukemia: results from a randomized, double-blind, phase 2 tria

J Sierra, J Szer, J Kassis, R Herrmann, M Lazzarino, X Thomas, SJ Noga, N Baker, R Dansey, A. Bosi

Research output: Contribution to journalArticleResearch

Original languageEnglish
Pages (from-to)195-195
JournalBMC Cancer
Issue number8
Publication statusPublished - 1 Jan 2008

Cite this